Optimization of Screening Strategies for COVID-19: Scoping Review (Preprint)
Preprint
- 17 November 2022
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND COVID-19 screening is an effective nonpharmaceutical intervention for identifying infected individuals and interrupting viral transmission. However, questions have been raised regarding its effectiveness in controlling the spread of novel variants and its high socioeconomic costs. Therefore, the optimization of COVID-19 screening strategies has attracted great attention. OBJECTIVE This review aims to summarize the evidence and provide a reference basis for the optimization of screening strategies for the prevention and control of COVID-19. METHODS We applied a methodological framework for scoping reviews and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) checklist. We conducted a scoping review of the present publications on the optimization of COVID-19 screening strategies. We searched the PubMed, Web of Science, and Elsevier ScienceDirect databases for publications up to December 31, 2022. English publications related to screening and testing strategies for COVID-19 were included. A data-charting form, jointly developed by 2 reviewers, was used for data extraction according to the optimization directions of the screening strategies. RESULTS A total of 2770 unique publications were retrieved from the database search, and 95 abstracts were retained for full-text review. There were 62 studies included in the final review. We summarized the results in 4 major aspects: the screening population (people at various risk conditions such as different regions and occupations; 12/62, 19%), the timing of screening (when the target population is tested before travel or during an outbreak; 12/62, 19%), the frequency of screening (appropriate frequencies for outbreak prevention, outbreak response, or community transmission control; 6/62, 10%), and the screening and detection procedure (the choice of individual or pooled detection and optimization of the pooling approach; 35/62, 56%). CONCLUSIONS This review reveals gaps in the optimization of COVID-19 screening strategies and suggests that a number of factors such as prevalence, screening accuracy, effective allocation of resources, and feasibility of strategies should be carefully considered in the development of future screening strategies.Keywords
All Related Versions
- Published version: JMIR Public Health and Surveillance, 10 (1), e44349.
This publication has 70 references indexed in Scilit:
- Cost analysis of coronavirus disease 2019 test strategies using pooled reverse transcriptase‐polymerase chain reaction techniqueJournal of Clinical Laboratory Analysis, 2022
- Effect of vaccination, border testing, and quarantine requirements on the risk of COVID-19 in New Zealand: A modelling studyInfectious Disease Modelling, 2021
- Optimal diagnostic test allocation strategy during the COVID‐19 pandemic and beyondStatistics in Medicine, 2021
- The effect of correlation and false negatives in pool testing strategies for COVID-19Health Care Management Science, 2021
- The impact of repeated mass antigen testing for COVID-19 on the prevalence of the diseaseJournal of Population Economics, 2021
- Optimal uses of pooled testing for COVID‐19 incorporating imperfect test performance and pool dilution effect: An application to congregate settings in Los Angeles CountyJournal of Medical Virology, 2021
- A reduction of the number of assays and turnaround time by optimizing polymerase chain reaction (PCR) pooled testing for SARS‐CoV‐2Journal of Medical Virology, 2021
- Evaluation of COVID-19 Testing Strategies for Repopulating College and University Campuses: A Decision Tree AnalysisJournal of Adolescent Health, 2021
- A simple approach to optimum pool size for pooled SARS-CoV-2 testingInternational Journal of Infectious Diseases, 2020
- Optimization of group size in pool testing strategy for SARS‐CoV‐2: A simple mathematical modelJournal of Medical Virology, 2020